Title : Benefit-risk assessment of rofecoxib in the treatment of osteoarthritis.

Pub. Date : 2004

PMID : 14756580






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This review focuses on the NSAID rofecoxib, one of the selective cyclo-oxygenase (COX)-2 inhibitors, which are claimed to be as effective as nonselective NSAIDs with better gastrointestinal tolerability. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens